Skip to main content

Table 1 Clinical characteristics of patients with non-CF bronchiectasis

From: Oxygen desaturation during the 6-min walk test as a risk for osteoporosis in non-cystic fibrosis bronchiectasis

 

Total (N = 66)

Non-desaturators (N = 21)

Desaturators (N = 45)

P

Age, yrs

65.2 ± 10.2 (62.6~67.7)

65.2 ± 8.6 (61.2~69.1)

65.2 ± 11.0(61.8~68.5)

0.930

Gender, female

51

14

37

0.210

HRCT score

10.5 ± 4.4 (9.4~11.7)

7.7 ± 3.6 (6.0~9.3)

11.9 ± 4 (10.7~13.2)

< 0.001

BMI (kg/m2)

21.8 ± 4.1 (20.8~22.8)

22.1 ± 2.9 (20.8~23.4)

21.7 ± 4.6 (20.3~23.1)

0.662

BMD T score

 Femoral neck

−3.2 ± 1.2 (−3.5~ − 2.9)

−2.4 ± 0.9 (− 2.7~ − 2.0)

− 3.6 ± 1.1 (−3.3~ − 3.9)

< 0.001

 Lumbar spine

−2.3 ± 1.2 (− 2.6~ − 2.0)

−1.6 ± 0.9 (− 2.0~ − 1.1)

−2.6 ± 1.2 (− 3.0~ − 2.3)

0.001

 Proximal hip

− 2.5 ± 1.2 (− 2.8~ − 2.2)

− 1.5 ± 0.8 (− 1.9~ − 1.2)

− 2.9 ± 1.0 (− 3.2~ − 2.6)

< 0.001

Osteoporosis, %

46 (70%)

9 (43%)

37 (82%)

0.005

Osteopenia, %

15 (23%)

9 (43%)

6 (13%)

 

Pulmonary function

 FVC, L

1.7 ± 0.7 (1.6~1.9)

2.2 ± 0.7 (1.9~2.5)

1.5 ± 0.6 (1.3~1.7)

< 0.001

 FVC, %

71.3 ± 21.7 (66.0~76.6)

81.4 ± 20.1 (72.2~90.5)

66.6 ± 21 (60.3~72.9)

0.009

 FEV1, L

1.2 ± 0.5 (1.1~1.3)

1.6 ± 0.5 (1.3~1.8)

1.0 ± 0.5 (0.9~1.2)

< 0.001

 FEV1, %

62.5 ± 24.0 (56.6~68.4)

71.8 ± 21.2 (62.2~81.5)

58.1 ± 24.2 (50.9~65.4)

0.024

 FEV1/FVC, %

69.7 ± 10.9 (67.1~72.4)

71.2 ± 9.7 (66.8~75.7)

69 ± 11.4 (65.6~72.5)

0.449

6MWT parameters

 SpO2 saturation

  Pre-exercise,%

93.6 ± 4.1 (92.6~94.6)

95.0 ± 2.0 (94.1~96.0)

92.9 ± 4.6 (91.5~94.3)

0.197

  Post-exercise,%

84.1 ± 7.8 (82.2~86.0)

92.1 ± 2.2 (91.1~93.1)

80.4 ± 6.5 (78.5~82.4)

< 0.001

 Borg score

  Pre-exercise

1.0 ± 1.3 (0.7~1.4)

0.5 ± 1.0 (0.1~1.0)

1.3 ± 1.4 (0.8~1.7)

0.032

  Post-exercise

4.4 ± 1.5 (4.0~4.7)

3.4 ± 0.9 (2.9~3.8)

4.9 ± 1.4 (4.5~5.3)

< 0.001

6MWD, M

417.7 ± 119.8 (388.2~477.1)

487.0 ± 65.0 (457.4~516.6)

385.3 ± 126.1 (347.4~423.2)

< 0.001

Severe exacerbation (times/year)

2.3 ± 4.0 (1.3~3.3)

0.8 ± 1.3 (0.2~1.4)

3.0 ± 4.6 (1.6~4.4)

0.023

Short-term systemic corticosteroid loadinga (days)

2.9 ± 6.6 (1.3~4.5)

0.7 ± 2.1 (− 0.3~1.6)

4.0 ± 7.7 (1.7~6.3)

0.0496

  1. Note: Data are presented as mean ± standard deviation, or number (percentage)
  2. Abbreviations: CF cystic fibrosis, HRCT high resolution computed tomography, BMI body mass index, BMD bone mineral density, FEV1 forced expiratory volume in 1 s, FVC forced volume capacity, 6MWT six minute walk test, SpO2 oxygen saturation by pulse oximetry, 6MWD six minute walk distance
  3. The data in the parenthesis of the continue variables indicate 95% confidence interval (CI)
  4. aShort-term systemic corticosteroid dosing: total days of prednisolone 20 mg per person